We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




New Endoscope Targets Colon Tumors

By MedImaging International staff writers
Posted on 18 May 2017
Print article
Image: The new endoscope will enable faster, more accurate colorectal cancer diagnosis (Photo courtesy of the Tyndall National Institute).
Image: The new endoscope will enable faster, more accurate colorectal cancer diagnosis (Photo courtesy of the Tyndall National Institute).
An innovative endoscope will use breakthrough photonics technology to enable rapid, accurate diagnosis of bowel polyps and early colon cancer.

The PhotonICs endoscope for improved in-vivo COLOn Cancer diagnosis and clinical decision support (PICCOLO), under development at Tyndall National Institute, Tecnalia, and other institutions, is a multimodal photonic endoscope with high sensitivity that will use both optical coherence tomography (OCT) and multi-photon tomography (MPT), combined with fluorescence technology, in order to facilitate real time computer aided diagnosis (CAD) of colon cancer via high-resolution structural and functional imaging.

The PICCOLO will be able to detail changes occurring at the cellular level, comparable to those obtained using traditional histological techniques. According to the researchers, the endoscope will not only provide a new approach in colon cancer detection, but its image-based diagnosis methods could be applied to diseases in other organs of the body. The PICCOLO multidisciplinary development team, which includes clinicians, photonics components and technology providers, endoscope providers, and medical software developers hope to have refined the first prototype by the end of 2018, and target clinical trials to begin around 2020.

“When multiple polyps are detected in a patient, the current gold standard procedure is to remove all of them, followed by microscopic tissue analysis,” said computer vision researcher Artzai Picon, PhD, of Tecnalia. “Removal of hyperplastic polyps, which carry no malignant potential, and the subsequent costly histolopathological analysis might be avoided through the use of the PICCOLO endoscope probe, which could allow image-based diagnosis without the need for tissue biopsies.”

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Silver Member
Mobile X-Ray Barrier
Lead Acrylic Mobile X-Ray Barriers
Under Table Shield
3 Section Double Pivot Under Table Shield
Gold Member
Radiation QA Tool
Accu-Gold 3

Print article

Channels

Ultrasound

view channel
Image: Structure of the proposed transparent ultrasound transducer and its optical transmittance (Photo courtesy of POSTECH)

Ultrasensitive Broadband Transparent Ultrasound Transducer Enhances Medical Diagnosis

The ultrasound-photoacoustic dual-modal imaging system combines molecular imaging contrast with ultrasound imaging. It can display molecular and structural details inside the body in real time without... Read more

Nuclear Medicine

view channel
Image: PET/CT of a 60-year-old male patient with clinical suspicion of lung cancer (Photo courtesy of EJNMMI Physics)

Early 30-Minute Dynamic FDG-PET Acquisition Could Halve Lung Scan Times

F-18 FDG-PET scans are a way to look inside the body using a special dye, and these scans can be either static or dynamic. Static scans happen 60 minutes after the dye is administered into the body, showing... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: The acquisition will expand IBA’s medical imaging quality assurance offering (Photo courtesy of Radcal)

IBA Acquires Radcal to Expand Medical Imaging Quality Assurance Offering

Ion Beam Applications S.A. (IBA, Louvain-La-Neuve, Belgium), the global leader in particle accelerator technology and a world-leading provider of dosimetry and quality assurance (QA) solutions, has entered... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.